Narrow search
Showing 1 - 10 of 13,163
Cover Image
« Responsible Care» et management durable: comportement volontaire ou réaction adaptative ? Généalogie et pratiques dans l'industrie chimique.
Berland, Nicolas; Loison, Marie-Claire - Université Paris-Dauphine
L'industrie chimique a mis en place de longue date un programme de gestion et de prévention des risques dénommé “Responsible Care” (« Engagement de Progrès » en Français). Ce programme préfigure, même s'il ne le recouvre pas exactement, le thème du développement durable apparu au...
Persistent link: https://www.econbiz.de/10008532697
Cover Image
"Responsible Care" and Sustainable Management: The Reciprocal Influence of Society - Management Practices
Berland, Nicolas; Loison, Marie-Claire - Université Paris-Dauphine (Paris IX) - 2006
Chemical industry's managers have developed since mid-1970' a management and prevention risk policy named “Responsible Care”. This policy was a first draft for a sustainable management even if these two concepts were not exactly synonymous. Through genealogy of this practice and its use in a...
Persistent link: https://www.econbiz.de/10011071811
Cover Image
« Responsible Care» et management durable: comportement volontaire ou réaction adaptative ? Généalogie et pratiques dans l'industrie chimique
Berland, Nicolas; Loison, Marie-Claire - Université Paris-Dauphine (Paris IX) - 2005
Chemical industry's managers have developed since mid-1970' a management and prevention risk policy named “Responsible Care”. This policy was a first draft for a sustainable management even if these two concepts were not exactly synonymous. Through genealogy of this practice and its use in a...
Persistent link: https://www.econbiz.de/10011072217
Cover Image
Global Framework for Differential Pricing of Pharmaceuticals
Daems, Rutger; Maes, Edith; Ramani, Shyama V. - United Nations University-Maastricht Economic Research … - 2011
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
Cover Image
Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
Santiago-Rodriguez, Fernando; Dutrenit, Gabriela - United Nations University, Maastricht Economic and … - 2010
systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by …
Persistent link: https://www.econbiz.de/10008693155
Cover Image
Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
Santiago-Rodriguez, Fernando; Dutrenit, Gabriela - United Nations University-Maastricht Economic Research … - 2010
systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by …
Persistent link: https://www.econbiz.de/10010712332
Cover Image
Corporate Responsibility in der forschenden Arzneimittelindustrie
Suchanek, Andreas; Lin-Hi, Nick - In: Journal of Economics and Statistics (Jahrbuecher fuer … 227 (2007) 5+6, pp. 547-562
Corporate Responsibility is a crucial concept in the pharmaceutical industry, especially for research-based pharmaceutical companies. Companies are faced with a tension between fulfilling normative expectations of solidarity and making profits under the pressure of competition. We argue that the...
Persistent link: https://www.econbiz.de/10008596500
Cover Image
Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry
Lacetera, Nicola - KITeS, Centre for Knowledge, Internationalization and … - 2000
literature on firm's boundaries and sectoral systems of innovation, we propose industry-specific variables for pharmaceuticals …
Persistent link: https://www.econbiz.de/10005087157
Cover Image
Breaking the Fence: Patent Rights and Biomedical Innovation in 'Technology Followers'
Gehl Sampath, Padmashree - United Nations University, Maastricht Economic and … - 2006
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti … difficult to predict the impact of patenting on biomedical innovation in developing and least developed countries. This paper … develops a framework of analysis for the impact of patent rights on biomedical innovation in "technology follower" developing …
Persistent link: https://www.econbiz.de/10005150790
Cover Image
Pharmaceutical Research Strategies
Phlippen, Sandra; Vermeersch, An - Tinbergen Institute - 2008
This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …
Persistent link: https://www.econbiz.de/10005137162